Thrombolysis for acute ischaemic stroke: Consumer involvement in design of new randomised controlled trial

British Medical Journal

Volumn 325, Issue 7361, 2002, Pages 415-417

  Koops, Liedeke ^a   Lindley, Richard I ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONSUMER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHICS; FEEDBACK SYSTEM; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESEARCH; RISK;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

ACUTE DISEASE; AGED; CEREBROVASCULAR ACCIDENT; CONSUMER PARTICIPATION; ETHICS, CLINICAL; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION SERVICES; INFORMED CONSENT; PAMPHLETS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; THROMBOLYTIC THERAPY;

EID: 0037167309     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Tissue plasminogen activator for acute ischemic stroke
2. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke
3. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
4. Clinical trials: A "ladyplan" for trial recruitment? - Everyone's business!
5. New approach for recruitment into randomised controlled trials
6. Thrombolytic treatment for acute ischaemic stroke: Consent can be ethical
7. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life
8. Patient preferences for stroke outcomes
9. Research involving critically ill subjects in emergency circumstances: New regulations, new challenges